Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel VEGFR2/PDGFR kinase inhibitor with antitumor and antiangiogenic activity presented by Bayer

Oct. 1, 2004

Inhibition of SOD1 via copper depletion results in inhibition of angiogenesis

Oct. 1, 2004

ABP-309: a second-generation VEGFR tyrosine kinase inhibitor with a promising preclinical profile

Oct. 1, 2004

First clinical results reported for AMG-706 in patients with advanced tumors

Oct. 1, 2004

Selective inhibitors of PKB/Akt designed at Astex

Oct. 1, 2004

Extension of indication recommended for Taxotere in E.U.

Sep. 30, 2004

Preliminary data reported from phase I trial of antiangiogenic peptide

Sep. 30, 2004

CombinatoRx and ABC2 establish brain cancer collaboration

Sep. 30, 2004

Statins show antiproliferative effects on pancreatic adenocarcinoma

Sep. 30, 2004

Orphan drug designation gives Gliadel exclusivity to 2010

Sep. 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...